radiation therapy

Research in Review

Hormone Therapy More Cost-Effective Than Chemotherapy for Patients With HR+/HER2- Metastatic Breast Cancer

05/06/2016

JCP Editors

A study of patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2–) metastatic breast cancer has found that treatment with first-line chemotherapy offers no survival...

...

05/06/2016

Journal of Clinical Pathways

Same Survival and Toxicity With APBI and WBI for Breast Cancer

05/04/2016

JCP Editors

Accelerated partial breast irradiation (APBI) leads to the same rates of survival and toxicity as whole breast irradiation (WBI) while also producing significantly better cosmetic results, according to phase 3 trial...

...

05/04/2016

Journal of Clinical Pathways

Radiation Therapy Better for Testicular Cancer Than Chemotherapy

05/02/2016

JCP Editors

Radiation therapy may be superior to chemotherapy for patients with stage 2a-b testicular cancer, according to results presented at European Society for Therapeutic Radiology and Oncology (ESTRO) 35 (April 29-May 3,...

...

05/02/2016

Journal of Clinical Pathways

Research in Review

Radiotherapy Plus Surgery Better for Older Patients With Soft-Tissue Sarcoma

04/29/2016

JCP Editors

Age may be a significant determinant of the effectiveness of radiotherapy in patients with soft-tissue sarcoma undergoing surgery, according to a recent study. While the survival rates for early-stage, soft-tissue...

Age...

04/29/2016

Journal of Clinical Pathways

Benefits of Using Comparative-Effectiveness Data in Lieu of Clinical Trials to Support Treatment Strategies

04/22/2016

JCP Editors

A lack of randomized controlled trials (RCTs) shouldn’t rule out the use of effective treatment strategies, such as stereotactic ablative radiotherapy (SABR), for lung cancer, urged a prominent oncologist recently....

A lack...

04/22/2016

Journal of Clinical Pathways

Research in Review

Stereotactic Body Radiation Therapy Results in Almost 100% Cure Rate For Patients With Prostate Cancer

04/22/2016

JCP Editors

A recent study showed a 98.6% cure rate at 5 years with stereotactic body radiation therapy (SBRT) in patients with low- or intermediate-risk prostate cancer. Current forms of radiation for prostate cancer are...

A...

04/22/2016

Journal of Clinical Pathways

Research in Review

Standard Therapy Only Used in Half of US Patients With Rectal Cancer

04/20/2016

JCP Editors

Despite being widely accepted as the standard of care for locally advanced rectal cancer, neoadjuvant chemoradiation (NACRT) is only used in about half of US patients with the disease, according to a recent...

...

04/20/2016

Journal of Clinical Pathways

Research in Review

Wide Variability in Radiation Therapy Following Neoadjuvant Chemotherapy for Patients With Breast Cancer

04/08/2016

JCP Editors

A study conducted by members of the American College of Surgeons has identified a need for greater uniformity and guidelines regarding radiation therapy following neoadjuvant chemotherapy in patients with initial...

A...

04/08/2016

Journal of Clinical Pathways

Research in Review

Adding Chemotherapy to Radiation Therapy Improves Long-Term Outcomes for Patients With Low-Grade Brain Tumors

04/08/2016

JCP Editors

The combination of chemotherapy and radiation therapy may improve progression-free survival (PFS) and overall survival in patients with grade 2 glioma, according to a recent study. Glioma is a form of brain cancer...

The...

04/08/2016

Journal of Clinical Pathways

Research in Review

Patients With Prostate Cancer Do Not Benefit From Higher Doses of Radiotherapy

04/06/2016

JCP Editors

While advances in technology have allowed physicians to administer higher doses of radiation to treat prostate cancer, results from a recent study have revealed that escalating dose may not help patients in the long...

While...

04/06/2016

Journal of Clinical Pathways